Assistant Professor
Clinical Research Division, Fred Hutch
Dr. Andrew Cowan is a hematologist-oncologist who specializes in treating patients with multiple myeloma and other blood disorders. He leads clinical trials of new treatments for these diseases, including the use of engineered immune cells, combination strategies and genomics data. An expert in trial design, Dr. Cowan evaluates research proposals as a member of Fred Hutchinson Cancer Research Center's Scientific Review Committee.
Assistant Professor of Medicine, Division of Medical Oncology
University of Washington School of Medicine
Physician
Seattle Cancer Care Alliance
Active Full Member
American Society of Hematology (ASH)
Active Full Member
American Society for Blood and Marrow Transplantation (ASBMT)
University of Washington, M.D., Fellowship
Multiple Myeloma
Amyloidosis
Multiple myeloma
AL amyloidosis treatment
— Dr. Andrew J. Cowan
Study Number: 9944
Phase: N/A
Study Number: 9952
Phase: I
Identifier: NCT03301220
Phase: III
Identifier: NCT03106779
Phase: III
Identifier: NCT03057795
Phase: II
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210.